Inhalation compositions comprising muscarinic receptor antagonist
US10105316B2 · kind B2 · utility
0Cited by
13References
47Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 27, 2013 |
| Grant date | Oct 23, 2018 |
| Priority date | — |
| Expiry date | Jun 27, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M2205/19
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to pharmaceutical powder compositions administered by means of inhalers. More particularly, it relates to pharmaceutical powder compositions having the content uniformity and the desired stability used in inhaler devices.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.